Molecular characteristics of gastric cancer with ERBB2 amplification

Gastric cancer is a prevalent malignancy with a high degree of heterogeneity, which has led to a poor therapeutic response. Though there are numerous HER2-targeted medicines for HER2+ gastric cancer, many trials have not indicated an improvement in overall survival. Here 29 ERBB2 amplification (ERBB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Dongyan, Xu, Hongping, Li, Longteng, Ju, Zheng, Zhai, Baiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405018/
https://www.ncbi.nlm.nih.gov/pubmed/37554835
http://dx.doi.org/10.1016/j.heliyon.2023.e18654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405018/
https://www.ncbi.nlm.nih.gov/pubmed/37554835
http://dx.doi.org/10.1016/j.heliyon.2023.e18654

Ejemplares similares